US2018127367A1PendingUtilityA1

Pro-Neurogenic Compounds

Assignee: BOARD OF REGENTS OF THE UNIVERISTY OF TEXAS SYSTEMPriority: Jan 9, 2009Filed: Jan 4, 2018Published: May 10, 2018
Est. expiryJan 9, 2029(~2.5 yrs left)· nominal 20-yr term from priority
A61P 9/10A61P 25/36A61P 25/24A61P 25/08A61P 25/02A61P 25/14A61P 25/28A61P 25/30A61P 27/02A61P 25/22A61P 25/16A61P 25/18A61K 31/4045A61K 31/4192A61K 31/4155C07D 209/08C07D 401/06C07D 495/04A61K 31/422A61K 31/437C07F 5/022C07D 209/86C07D 209/82C07D 209/88A61K 31/4439C07D 405/12C07D 401/12C07D 471/04C07D 413/06C07D 403/12A61P 25/00A61K 31/506A61P 21/02C07D 403/06A61K 31/403A61K 31/4188A61K 31/404
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and hypothalamic neurogenesis) and/or protecting neuronal cell from cell death. Various compounds are disclosed herein. In vivo activity tests suggest that these compounds may have therapeutic benefits in neuropsychiatric and/or neurodegenerative diseases such as schizophrenia, major depression, bipolar disorder, normal aging, epilepsy, traumatic brain injury, post-traumatic stress disorder, Parkinson's disease, Alzheimer's disease, Down syndrome, spinocerebellar ataxia, amyotrophic lateral sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of a neuro-active drug, retinal degeneration, spinal cord injury, peripheral nerve injury, physiological weight loss associated with various conditions, as well as cognitive decline associated with normal aging, chemotherapy, and the like.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A compound having formula (III) or a pharmaceutically acceptable salt thereof: 
       
         
           
           
               
               
           
         
         wherein: 
         each of R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , and R 8  is independently selected from hydrogen, halo, hydroxyl, sulfhydryl, C 1 -C 6  alkoxy, C 1 -C 6  thioalkoxy, C 1 -C 6  haloalkoxy, C 1 -C 6  thiohaloalkoxy, C 1 -C 6  alkyl, C 1 -C 6  haloalkyl, C 2 -C 6  alkynyl, cyclopropyl, —N 3 , cyano, —NH 2 , —NH(C 1 -C 6  alkyl), —N(C 1 -C 6  alkyl) 2 , —NHC(O)(C 1 -C 6  alkyl), and nitro; 
         R 3  is selected from halo, hydroxyl, sulfhydryl, C 1 -C 6  alkoxy, C 1 -C 6  thioalkoxy, C 1 -C 6  haloalkoxy, C 1 -C 6  thiohaloalkoxy, C 1 -C 6  alkyl, C 1 -C 6  haloalkyl, C 2 -C 6  alkynyl, cyclopropyl, —N 3 , cyano, —NH 2 , —NH(C 1 -C 6  alkyl), —N(C 1 -C 6  alkyl) 2 , —NHC(O)(C 1 -C 6  alkyl), and nitro; 
         each of L 1  and L 2  is, independently, C 1 -C 3  alkylene, which is optionally substituted with from 1-2 independently selected R c ; 
         A is CR A1 R A2 , wherein one of R A1  and R A2  is halo, and the other of R A1  and R A2  is hydrogen, halo, C 1 -C 3  alkyl, and hydroxyl; 
         Z is —NR 10 R 11  or —OR 12  or —S(O) n R 13 , wherein n is 0, 1, or 2; 
         each of R 10  and R 11  is independently selected from:
 (a) hydrogen; 
 (b) C 6 -C 10  aryl that is optionally substituted with from 1-4 R b ; or 
 (c) heteroaryl containing from 5-14 ring atoms, wherein from 1-6 of the ring atoms is independently selected from N, NH, N(C 1 -C 3  alkyl), O, and S; and wherein said heteroaryl is optionally substituted with from 1-4 R b ; 
 (d) C 1 -C 6  alkyl or C 1 -C 6  haloalkyl, each of which is optionally substituted with from 1-3 R d ; and 
 (e) —C(O)(C 1 -C 6  alkyl), —C(O)(C 1 -C 6  haloalkyl), or —C(O)O(C 1 -C 6  alkyl); 
 
         wherein one of R 10  and R 11  is (b) or (c); 
         each of R 12  and R 13  is:
 (i) C 6 -C 10  aryl that is optionally substituted with from 1-4 R b ; or 
 (ii) heteroaryl containing from 5-14 ring atoms, wherein from 1-6 of the ring atoms is independently selected from N, NH, N(C 1 -C 3  alkyl), O, and S; and wherein said heteroaryl is optionally substituted with from 1-4 R b ; 
 
         R b  at each occurrence is independently selected from the substituents delineated in (aa) through (dd) below:
 (aa) C 1 -C 6  alkoxy; C 1 -C 6  haloalkoxy; C 1 -C 6  thioalkoxy; C 1 -C 6  thiohaloalkoxy; —O—(CH 2 ) 1-3 —[O(CH 2 ) 1-3 ] 1-3 —H; C 1 -C 6  alkyl, C 1 -C 6  haloalkyl, —NH(C 1 -C 6  alkyl), —N(C 1 -C 6  alkyl) 2 , —NHC(O)(C 1 -C 6  alkyl); 
 (bb) halo; hydroxyl; cyano; nitro; —NH 2 ; azido; sulfhydryl; C 2 -C 6  alkenyl; C 2 -C 6  alkynyl; —C(O)H; —C(O)(C 1 -C 6  alkyl); —C(O)(C 1 -C 6  haloalkyl); C(O)OH; —C(O)O(C 1 -C 6  alkyl); —C(O)NH 2 ; —C(O)NH(C 1 -C 6  alkyl); —C(O)N(C 1 -C 6  alkyl) 2 ; —SO 2 (C 1 -C 6  alkyl); —SO 2 NH 2 ; —SO 2 NH(C 1 -C 6  alkyl); —SO 2 N(C 1 -C 6  alkyl) 2 ; 
 (cc) C 3 -C 6  cycloalkyl or heterocyclyl containing from 5-6 ring atoms, wherein from 1-2 of the ring atoms of the heterocyclyl is independently selected from N, NH, N(C 1 -C 6  alkyl), NC(O)(C 1 -C 6  alkyl), O, and S; and 
 (dd) phenyl or heteroaryl containing from 5-6 ring atoms, wherein from 1-2 of the ring atoms of the heteroaryl is independently selected from N, NH, N(C 1 -C 3  alkyl), O, and S; wherein each of said phenyl and heteroaryl is optionally substituted with from 1-3 substituents independently selected from halo; hydroxyl; cyano; nitro; —NH 2 ; —NH(C 1 -C 6  alkyl), —N(C 1 -C 6  alkyl) 2 , —NHC(O)(C 1 -C 6  alkyl), C 1 -C 6  alkoxy; C 1 -C 6  haloalkoxy; C 1 -C 6  thioalkoxy; C 1 -C 6  thiohaloalkoxy; C 1 -C 6  alkyl, and C 1 -C 6  haloalkyl; 
 
         R c  at each occurrence is, independently selected from halo, C 1 -C 6  alkoxy, C 1 -C 6  thioalkoxy, C 1 -C 6  haloalkoxy, C 1 -C 6  thiohaloalkoxy, C 1 -C 6  alkyl, C 1 -C 6  haloalkyl, —NH 2 , —NH(C 1 -C 6  alkyl), —N(C 1 -C 6  alkyl) 2 , —NHC(O)(C 1 -C 6  alkyl), and cyano; and 
         R d  at each occurrence is, independently selected from hydroxyl, C 1 -C 6  alkoxy, C 1 -C 6  thioalkoxy, C 1 -C 6  haloalkoxy, C 1 -C 6  thiohaloalkoxy, C 1 -C 6  alkyl, C 1 -C 6  haloalkyl, —NH 2 , —NH(C 1 -C 6  alkyl), N(C 1 -C 6  alkyl) 2 , —NHC(O)(C 1 -C 6  alkyl), and cyano. 
       
     
     
         2 . The compound or salt of  claim 1 , wherein R 3  is halo. 
     
     
         3 . The compound or salt of  claim 2 , wherein R 3  is bromo. 
     
     
         4 . The compound or salt of  claim 3 , wherein each of R 1 , R 2 , and R 4  is hydrogen. 
     
     
         5 . The compound or salt of  claim 4 , wherein R 6  is selected from halo, C 1 -C 6  alkyl, C 1 -C 6  haloalkyl, C 2 -C 6  alkynyl, cyclopropyl, —N 3 , and cyano. 
     
     
         6 . The compound or salt of  claim 4 , wherein R 6  is halo or C 1 -C 6  alkyl. 
     
     
         7 . The compound or salt of  claim 4 , wherein R 6  is halo. 
     
     
         8 . The compound or salt of  claim 4 , wherein R 6  is bromo. 
     
     
         9 . The compound or salt of  claim 8 , wherein each of R 5 , R 7 , and R 8  is hydrogen. 
     
     
         10 . The compound or salt of  claim 4 , wherein Z is —NR 10 R 11 . 
     
     
         11 . The compound or salt of  claim 10 , wherein one of R 10  and R 11  is:
 (b) C 6 -C 10  aryl that is optionally substituted with from 1-4 R b ; or   (c) heteroaryl containing from 5-14 ring atoms, wherein from 1-6 of the ring atoms is independently selected from N, NH, N(C 1 -C 3  alkyl), O, and S; and wherein said heteroaryl is optionally substituted with from 1-4 R b ;   and the other of R 10  and R 11  is hydrogen.   
     
     
         12 . The compound or salt of  claim 4 , wherein Z is —OR 12 . 
     
     
         13 . The compound or salt of  claim 12 , wherein R 12  is C 6 -C 10  aryl that is optionally substituted with from 1-4 R b .

Join the waitlist — get patent alerts

Track US2018127367A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.